DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 4 of 4 descriptions
Filter by
Reset
|
No.
Drug (Description in trials)
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
Disease ID
1
Caffeine
[1]
Caffeine
Caffeine
[2]
Caffeine
Caffeine
,
Caffeine
hydrate
💬
1.
Caffeine
×
Name
Other Names
Caffeine
Caffeine (USP)
Anhydrous caffeine (JP18)
Anhydrous caffeine (TN)
Respia (TN)
Caffeine
hydrate
Caffeine hydrate (JP18)
Caffeine monohydrate
Caffeine (TN)
[11]
ADORA1
ADORA1
,
ADORA2A
,
PDE1B
,
PDE2A
,
PDE3A
,
PDE3B
,
PDE4A
,
PDE4B
,
PDE4C
,
PDE4D
,
PDE5A
💬
1.
Caffeine
×
Name
Full Name
ADORA1
adenosine A1 receptor
ADORA2A
adenosine A2a receptor
PDE1B
phosphodiesterase 1B
PDE2A
phosphodiesterase 2A
PDE3A
phosphodiesterase 3A
PDE3B
phosphodiesterase 3B
PDE4A
phosphodiesterase 4A
PDE4B
phosphodiesterase 4B
PDE4C
phosphodiesterase 4C
PDE4D
phosphodiesterase 4D
PDE5A
phosphodiesterase 5A
[22]
Alcoholism
Alcoholism
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Glucagon signaling pathway
,
Insulin signaling pathway
,
Metabolic pathways
,
Morphine addiction
,
Neuroactive ligand-receptor interaction
,
Olfactory transduction
,
Parathyroid hormone synthesis, secretion and action
,
Parkinson disease
,
Progesterone-mediated oocyte maturation
,
Purine metabolism
,
Rap1 signaling pathway
,
Regulation of lipolysis in adipocytes
,
Renin secretion
,
Sphingolipid signaling pathway
,
Taste transduction
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[22]
Alcoholism
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pa
...
[8]
2
2
,
6
,
21
,
46
,
78
,
96
,
97
,
265
💬
1.
Caffeine
×
Disease ID
Name
2
Amyotrophic lateral sclerosis
6
Parkinson disease
21
Mitochondrial disease
46
Malignant rheumatoid arthritis
78
Hypopituitarism
96
Crohn disease
97
Ulcerative colitis
265
Lipodystrophy
2
Caffeine
100-200 mg BID
[1]
Caffeine
Caffeine
[2]
Caffeine
Caffeine
,
Caffeine
hydrate
💬
2.
Caffeine
100-200 mg BID
×
Name
Other Names
Caffeine
Caffeine (USP)
Anhydrous caffeine (JP18)
Anhydrous caffeine (TN)
Respia (TN)
Caffeine
hydrate
Caffeine hydrate (JP18)
Caffeine monohydrate
Caffeine (TN)
[11]
ADORA1
ADORA1
,
ADORA2A
,
PDE1B
,
PDE2A
,
PDE3A
,
PDE3B
,
PDE4A
,
PDE4B
,
PDE4C
,
PDE4D
,
PDE5A
💬
2.
Caffeine
100-200 mg BID
×
Name
Full Name
ADORA1
adenosine A1 receptor
ADORA2A
adenosine A2a receptor
PDE1B
phosphodiesterase 1B
PDE2A
phosphodiesterase 2A
PDE3A
phosphodiesterase 3A
PDE3B
phosphodiesterase 3B
PDE4A
phosphodiesterase 4A
PDE4B
phosphodiesterase 4B
PDE4C
phosphodiesterase 4C
PDE4D
phosphodiesterase 4D
PDE5A
phosphodiesterase 5A
[22]
Alcoholism
Alcoholism
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Glucagon signaling pathway
,
Insulin signaling pathway
,
Metabolic pathways
,
Morphine addiction
,
Neuroactive ligand-receptor interaction
,
Olfactory transduction
,
Parathyroid hormone synthesis, secretion and action
,
Parkinson disease
,
Progesterone-mediated oocyte maturation
,
Purine metabolism
,
Rap1 signaling pathway
,
Regulation of lipolysis in adipocytes
,
Renin secretion
,
Sphingolipid signaling pathway
,
Taste transduction
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[22]
Alcoholism
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pa
...
[1]
6
6
💬
2.
Caffeine
100-200 mg BID
×
Disease ID
Name
6
Parkinson disease
3
Caffeine
alkaloid
[1]
Caffeine
Caffeine
[2]
Caffeine
Caffeine
,
Caffeine
hydrate
💬
3.
Caffeine
alkaloid
×
Name
Other Names
Caffeine
Caffeine (USP)
Anhydrous caffeine (JP18)
Anhydrous caffeine (TN)
Respia (TN)
Caffeine
hydrate
Caffeine hydrate (JP18)
Caffeine monohydrate
Caffeine (TN)
[11]
ADORA1
ADORA1
,
ADORA2A
,
PDE1B
,
PDE2A
,
PDE3A
,
PDE3B
,
PDE4A
,
PDE4B
,
PDE4C
,
PDE4D
,
PDE5A
💬
3.
Caffeine
alkaloid
×
Name
Full Name
ADORA1
adenosine A1 receptor
ADORA2A
adenosine A2a receptor
PDE1B
phosphodiesterase 1B
PDE2A
phosphodiesterase 2A
PDE3A
phosphodiesterase 3A
PDE3B
phosphodiesterase 3B
PDE4A
phosphodiesterase 4A
PDE4B
phosphodiesterase 4B
PDE4C
phosphodiesterase 4C
PDE4D
phosphodiesterase 4D
PDE5A
phosphodiesterase 5A
[22]
Alcoholism
Alcoholism
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Glucagon signaling pathway
,
Insulin signaling pathway
,
Metabolic pathways
,
Morphine addiction
,
Neuroactive ligand-receptor interaction
,
Olfactory transduction
,
Parathyroid hormone synthesis, secretion and action
,
Parkinson disease
,
Progesterone-mediated oocyte maturation
,
Purine metabolism
,
Rap1 signaling pathway
,
Regulation of lipolysis in adipocytes
,
Renin secretion
,
Sphingolipid signaling pathway
,
Taste transduction
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[22]
Alcoholism
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pa
...
[1]
6
6
💬
3.
Caffeine
alkaloid
×
Disease ID
Name
6
Parkinson disease
4
Dextromethorphan and
Caffeine
[2]
Caffeine
Caffeine
,
Dextromethorphan
[3]
Caffeine
Caffeine
,
Caffeine
hydrate
,
Dextromethorphan
💬
4. Dextromethorphan and
Caffeine
×
Name
Other Names
Caffeine
Caffeine (USP)
Anhydrous caffeine (JP18)
Anhydrous caffeine (TN)
Respia (TN)
Caffeine
hydrate
Caffeine hydrate (JP18)
Caffeine monohydrate
Caffeine (TN)
Dextromethorphan
Dextromethorphan (USP)
[17]
ADORA1
ADORA1
,
ADORA2A
,
GRIN1
,
GRIN2A
,
GRIN2B
,
GRIN2C
,
GRIN2D
,
PDE1B
,
PDE2A
,
PDE3A
,
PDE3B
,
PDE4A
,
PDE4B
,
PDE4C
,
PDE4D
,
PDE5A
,
SIGMAR1
💬
[17]
ADORA1
,
ADORA2A
,
GRIN1
,
GRIN2A
,
GRIN2B
,
GRIN2C
,
GRIN2D
,
PDE1B
,
PDE2A
,
PDE3A
,
PDE3B
,
PDE4A
,
PDE4B
,
PDE4C
,
PDE4
...
4. Dextromethorphan and
Caffeine
×
Name
Full Name
ADORA1
adenosine A1 receptor
ADORA2A
adenosine A2a receptor
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
GRIN2A
glutamate ionotropic receptor NMDA type subunit 2A
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
GRIN2C
glutamate ionotropic receptor NMDA type subunit 2C
GRIN2D
glutamate ionotropic receptor NMDA type subunit 2D
PDE1B
phosphodiesterase 1B
PDE2A
phosphodiesterase 2A
PDE3A
phosphodiesterase 3A
PDE3B
phosphodiesterase 3B
PDE4A
phosphodiesterase 4A
PDE4B
phosphodiesterase 4B
PDE4C
phosphodiesterase 4C
PDE4D
phosphodiesterase 4D
PDE5A
phosphodiesterase 5A
SIGMAR1
sigma non-opioid intracellular receptor 1
[37]
Alcoholism
Alcoholism
,
Aldosterone synthesis and secretion
,
Alzheimer disease
,
Amphetamine addiction
,
Amyotrophic lateral sclerosis
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Circadian entrainment
,
Cocaine addiction
,
Dopaminergic synapse
,
Glucagon signaling pathway
,
Glutamatergic synapse
,
Huntington disease
,
Insulin signaling pathway
,
Long-term potentiation
,
Metabolic pathways
,
Morphine addiction
,
Neuroactive ligand-receptor interaction
,
Nicotine addiction
,
Olfactory transduction
,
Parathyroid hormone synthesis, secretion and action
,
Parkinson disease
,
Pathways of neurodegeneration - multiple diseases
,
Prion disease
,
Progesterone-mediated oocyte maturation
,
Purine metabolism
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Regulation of lipolysis in adipocytes
,
Renin secretion
,
Sphingolipid signaling pathway
,
Spinocerebellar ataxia
,
Systemic lupus erythematosus
,
Taste transduction
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[37]
Alcoholism
,
Aldosterone synthesis and secretion
,
Alzheimer disease
,
Amphetamine addiction
,
Amyo
...
[1]
78
78
💬
4. Dextromethorphan and
Caffeine
×
Disease ID
Name
78
Hypopituitarism